Study: NCT01059786

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: Treatment of infusion-related symptoms with diphenhydramine is recommended.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: Treatment of infusion-related symptoms with diphenhydramine is recommended.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Description: Treatment of infusion-related symptoms with diphenhydramine is recommended.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Description: Treatment of infusion-related symptoms with diphenhydramine is recommended.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: Treatment of infusion-related symptoms with diphenhydramine is recommended.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Epinephrine should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Epinephrine should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: Epinephrine should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: Epinephrine should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Epinephrine should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihistamines
Description: Antihistamines should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihistamines
Description: Antihistamines should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antihistamines
Description: Antihistamines should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antihistamines
Description: Antihistamines should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihistamines
Description: Antihistamines should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Description: Corticosteroids should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Description: Corticosteroids should be available for immediate use in the event of a hypersensitivity reaction to Rituximab.